229 related articles for article (PubMed ID: 14729944)
1. Iron-mediated degradation of IRP2, an unexpected pathway involving a 2-oxoglutarate-dependent oxygenase activity.
Wang J; Chen G; Muckenthaler M; Galy B; Hentze MW; Pantopoulos K
Mol Cell Biol; 2004 Feb; 24(3):954-65. PubMed ID: 14729944
[TBL] [Abstract][Full Text] [Related]
2. The pathway for IRP2 degradation involving 2-oxoglutarate-dependent oxygenase(s) does not require the E3 ubiquitin ligase activity of pVHL.
Wang J; Pantopoulos K
Biochim Biophys Acta; 2005 Mar; 1743(1-2):79-85. PubMed ID: 15777842
[TBL] [Abstract][Full Text] [Related]
3. Sodium nitroprusside promotes IRP2 degradation via an increase in intracellular iron and in the absence of S nitrosylation at C178.
Wang J; Fillebeen C; Chen G; Andriopoulos B; Pantopoulos K
Mol Cell Biol; 2006 Mar; 26(5):1948-54. PubMed ID: 16479012
[TBL] [Abstract][Full Text] [Related]
4. Oxygen and iron regulation of iron regulatory protein 2.
Hanson ES; Rawlins ML; Leibold EA
J Biol Chem; 2003 Oct; 278(41):40337-42. PubMed ID: 12888568
[TBL] [Abstract][Full Text] [Related]
5. Iron-dependent degradation of IRP2 requires its C-terminal region and IRP structural integrity.
Wang J; Chen G; Lee J; Pantopoulos K
BMC Mol Biol; 2008 Jan; 9():15. PubMed ID: 18226225
[TBL] [Abstract][Full Text] [Related]
6. The role of endogenous heme synthesis and degradation domain cysteines in cellular iron-dependent degradation of IRP2.
Bourdon E; Kang DK; Ghosh MC; Drake SK; Wey J; Levine RL; Rouault TA
Blood Cells Mol Dis; 2003; 31(2):247-55. PubMed ID: 12972033
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide inhibits the degradation of IRP2.
Wang J; Chen G; Pantopoulos K
Mol Cell Biol; 2005 Feb; 25(4):1347-53. PubMed ID: 15684386
[TBL] [Abstract][Full Text] [Related]
8. Redox control of iron regulatory protein 2 stability.
Hausmann A; Lee J; Pantopoulos K
FEBS Lett; 2011 Feb; 585(4):687-92. PubMed ID: 21281640
[TBL] [Abstract][Full Text] [Related]
9. Iron regulatory protein 2 turnover through a nonproteasomal pathway.
Chang AH; Jeong J; Levine RL
J Biol Chem; 2011 Jul; 286(27):23698-707. PubMed ID: 21558272
[TBL] [Abstract][Full Text] [Related]
10. HOIL-1 is not required for iron-mediated IRP2 degradation in HEK293 cells.
Zumbrennen KB; Hanson ES; Leibold EA
Biochim Biophys Acta; 2008 Feb; 1783(2):246-52. PubMed ID: 17822790
[TBL] [Abstract][Full Text] [Related]
11. Cysteine oxidation regulates the RNA-binding activity of iron regulatory protein 2.
Zumbrennen KB; Wallander ML; Romney SJ; Leibold EA
Mol Cell Biol; 2009 Apr; 29(8):2219-29. PubMed ID: 19223469
[TBL] [Abstract][Full Text] [Related]
12. Involvement of heme regulatory motif in heme-mediated ubiquitination and degradation of IRP2.
Ishikawa H; Kato M; Hori H; Ishimori K; Kirisako T; Tokunaga F; Iwai K
Mol Cell; 2005 Jul; 19(2):171-81. PubMed ID: 16039587
[TBL] [Abstract][Full Text] [Related]
13. A role for lysosomes in the turnover of human iron regulatory protein 2.
Dycke C; Charbonnier P; Pantopoulos K; Moulis JM
Int J Biochem Cell Biol; 2008; 40(12):2826-32. PubMed ID: 18582596
[TBL] [Abstract][Full Text] [Related]
14. Requirements for iron-regulated degradation of the RNA binding protein, iron regulatory protein 2.
Iwai K; Klausner RD; Rouault TA
EMBO J; 1995 Nov; 14(21):5350-7. PubMed ID: 7489724
[TBL] [Abstract][Full Text] [Related]
15. Excess capacity of the iron regulatory protein system.
Wang W; Di X; D'Agostino RB; Torti SV; Torti FM
J Biol Chem; 2007 Aug; 282(34):24650-9. PubMed ID: 17604281
[TBL] [Abstract][Full Text] [Related]
16. S-nitrosylation of IRP2 regulates its stability via the ubiquitin-proteasome pathway.
Kim S; Wing SS; Ponka P
Mol Cell Biol; 2004 Jan; 24(1):330-7. PubMed ID: 14673166
[TBL] [Abstract][Full Text] [Related]
17. Altered body iron distribution and microcytosis in mice deficient in iron regulatory protein 2 (IRP2).
Galy B; Ferring D; Minana B; Bell O; Janser HG; Muckenthaler M; Schümann K; Hentze MW
Blood; 2005 Oct; 106(7):2580-9. PubMed ID: 15956281
[TBL] [Abstract][Full Text] [Related]
18. Human iron regulatory protein 2 is easily cleaved in its specific domain: consequences for the haem binding properties of the protein.
Dycke C; Bougault C; Gaillard J; Andrieu JP; Pantopoulos K; Moulis JM
Biochem J; 2007 Dec; 408(3):429-39. PubMed ID: 17760563
[TBL] [Abstract][Full Text] [Related]
19. Identification of the ubiquitin-protein ligase that recognizes oxidized IRP2.
Yamanaka K; Ishikawa H; Megumi Y; Tokunaga F; Kanie M; Rouault TA; Morishima I; Minato N; Ishimori K; Iwai K
Nat Cell Biol; 2003 Apr; 5(4):336-40. PubMed ID: 12629548
[TBL] [Abstract][Full Text] [Related]
20. Loss of the von Hippel Lindau tumor suppressor disrupts iron homeostasis in renal carcinoma cells.
Alberghini A; Recalcati S; Tacchini L; Santambrogio P; Campanella A; Cairo G
J Biol Chem; 2005 Aug; 280(34):30120-8. PubMed ID: 15985433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
